Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis

OBJECTIVE: Recent years have seen new evidence on the efficacy and safety of dual antiplatelet therapy for secondary stroke prevention. We updated a meta-analysis of randomised controlled trials evaluating dual antiplatelet versus monotherapy for patients with acute non-cardioembolic ischaemic strok...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yingying, Zhou, Mengyuan, Zhong, Xi, Wang, Yongjun, Zhao, Xingquan, Liu, Liping, Wang, Yilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047341/
https://www.ncbi.nlm.nih.gov/pubmed/30022798
http://dx.doi.org/10.1136/svn-2018-000168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047341/
https://www.ncbi.nlm.nih.gov/pubmed/30022798
http://dx.doi.org/10.1136/svn-2018-000168

Ejemplares similares